Abstract
Hepatocellular carcinoma (НСС) is associated with liver cirrhosis in 80% of cases and when the tumor is diagnosed, the very poor hepatic function, due to the underlying liver disease, is so frequent that extended surgical resection is contraindicated in most cases. Because of the poor prognosis of nonresectable HCC, an aggressive approach is justified. Systemic or intraarterial chemotherapy has been used for years but has such a poor objective response rate in any of the large reported series that it has almost been abandoned. At the same time, the treatment of HCC by transcatheter arterial embolization (TAE) of the hepatic artery (ROCHE 1978) and then by combination of occlusion and regional chemotherapy (transcatheter hepatic arterial chemoembolization, TACE) has been investigated and developed since the 1970s. In the early 1980s, the ability of Lipiodol to selectively target hepatic tumors when injected intraarterially was reported by Japanese authors and developed as a complementary therapeutic tool; and nowadays transcatheter hepatic arterial treatments such as TAE, TACE, Lipiodol-TACE (L-TACE) or Lipiodol chemotherapy (L-TAC) play an important role in the therapeutic management of НСС.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adachi E, Matsumata T, Nishizaki T, Hashimoto H, Tsuneyoshi M, Sugimachi K, (1993) Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 72:3593–3598
Bartolozzi C, Lencioni R, Caramella D, et al (1995) Treatment of large НСС: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197:812–818
Bismuth H, Morino M, Sherlock D, et al (1992) Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163:387–394
Bronowicki JP, Vetter D, Dumas F, et al (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74:16–24
Bronowicki JP, Boudjema K, Chone L, et al (1996) Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 24:293–300
Bruix J, Llovet JM, Castells A, et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578–1583
Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH, (1994) Transarterial embolization with or without cisplatin treatment of hepatocellular carcinoma. Cancer 74:2449–2453
Chung JW, Park JH, Im JG, Han JK, Han MC (1993) Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187:689–693
Chung JW, Park JH, Han JK, Choi BI, Han MC (1995) Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR 165:315–321
Dazai Y, Katoh T, Katoh I, Sueda S, Yoshida R (1989) A rare case of chemoembolization therapy for metastatic right atrial tumor thrombus associated with hepatocellular carcinoma. Chest 96:434–436
De Baère T, Dufaux J, Roche A, Counnord JL, Berthault MF (1995) Circulatory modifications induced by intra-arte-rial injections of iodized oil and emulsions of iodized oil and doxorubicin. Radiology 194:165–170
De Baère T, Zhang X, Aubert B, et al (1996a) Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology 201:731–735
De Baère T, Amenabar J, Lagrange C, Roche A (1996b) Severe infectious complications after hepatic locoregional therapy. Hepatology 23:1436–1440
De Baère T, Denys A, Briquet R, Chevallier P, Laurent A, Roche A (1998) Modifications of arterial and portal hemodynamic after injection of iodized oils and emulsions of iodized oil in the hepatic artery: experimental study. J Vasc Interv Radiol 9:305–310
Derhy S, Bessis L, Atallah R, Ajavon Y, Eisele G, Roche A (1990) Reperméabilisation portale après chimiothérapie Lipiodolée intra-artérielle au cours d’un hépatocarcinome. A propos de 3 cas. Gastroenterol Clin Biol 14:893–895
Fukushima S, Kubota M, Kojima T, et a1 (1992) Preparation and evaluation of two formulations: cisplatin suspension in Lipiodol and polylactic acid microspheres containing aclarubicin hydrochloride for hepatic arterial administration therapy for hepatocellular carcinoma. Reg Cancer Treat 1–2:36–39
Groupe d’étude et de traitement du carcinome hépatocellulaire (1995) A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261
Gunji T, Kawauchi N, Ohnishi S, et al (1992) Treatment of hepatocellular carcinoma associated with advanced cirrhosis by transcatheter arterial chemoembolization using autologous blood clot: a preliminary report. Hepatology 15:252–257
Harada T, Matsuo K, Inoue T (1996) Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma. Ann Surg 224:4–9
Hashimoto T, Nakamura H, Hori S, et al (1995) Hepatocellular carcinoma: efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. Cardiovasc Intervent Radiol 18:82–86
Hatanaka Y, Yamashita Y, Takahashi M, et a1 (1995) Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 195:747–752
Higuchi T, Kikuchi M, Okazaki M, (1994) Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 73:2259–2267
Imai Y (1995) Transcatheter arterial chemoembolization for postoperative recurrent hepatocellular carcinoma: therapeutic results in correlation with radiologic findings and treatment methods. Nippon Igaku Hoshasen Gakkai Zasshi 55:395–401
Inoue Y, Nakamura H, Takashima S, Yamazaki K, Toyoshima H, Iwasaki M, (1991a) Biloma following transcatheter oily chemoembolization. Radiat Med 9:57–60
Inoue K, Akaji H, Nakamura H, (1991b) Transcatheter oily chemoembolization for the treatment of large hepatocellular carcinoma with an accompanying tumor thrombus in the right main branch of the portal vein and arterioportal shunting: report of one patient still surviving after more than seven years. Radiat Med 9):105–107
Kan Z (1996) Dynamic study of iodized oil in the liver and blood supply to hepatic tumors: an experimental investigation in several animals species. Acta Radiol 37(S):257–258
Kan Z, Ivancev K, Нägerstrand I, et a1 (1993) In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 187:621–626
Kasugai H, Kojima J, Tatsuta M, et al (1989) Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 97:965–971
Katsumori T, Fujita M, Satoh O, et a1 (1993) Transcatheter hepatic segmental chemo-Lipiodol-embolization against hepatocellular carcinoma accompanied by tumor thrombosis in the portal vein. Nippon Igaku Hoshasen Gakkai Zasshi 25:713–715
Kim JH, Chung JW, Han JK, Park JH, Choi BI, Han MC (1995) Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. J Vasc Interv Radiol 6:71–74.
Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Cancer 79:2087–2093
Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY (1995), Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization.J Hepatol 23:563–568
Majno PE, Adam R, Bismuth H, et a1 (1997) Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226:688–703
Matsui O, Kadoya M, Yoshikawa J, et al (1993) Small hepatocellular carcinoma: treatment with subsegmental tanscatheter arterial embolization. Radiology 188:79–83
Miller D, O’Leary T, Girton M, (1987) Distribution of iodized oil within the liver after hepatic arterial injection. Radiology 162:849–852
Molgaard CP, Teitelbaum GP, Pentecost MJ, et al (1990) Intraarterial administration of lidocaine for analgesia in hepatic chemoembolization. J Vasc Interv Radiol 1:81–85
Mondazzi L, Bottelli R, Brambilla G, et al. (1994) Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 19:1115–1123
Murakami R, Yoshimatsu S, Yamashita Y, Sagara K, Arakcawa A, Takahashi M, (1994) Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlition between Lipiodol accumulation pattern and local recurrence. Acta Radiol 35:576–580
Nagashima T, Kikuchi T, Yamamoto H, Asano T, Isono K (1992) The treatment for recurrent hepatocellular carcinoma in residual liver. Reg Cancer Treat 1–2:40–42
Nagasue N, Galizia G, Kohno H, et al. (1989) Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 106:81–86
Nakamura H, Hashimoto T. Oi H, Sawada S (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783–786
Nakamura H, Hashimoto T, Inoue Y, Inoue K, Akaji H, Sawada S (1990) Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter). Radiat Med 8:188–190
Nakamura H, Mitani T, Murakami T, et al (1994) Five-year survival aftervtranscatheter chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 33(Suppl):89–93
Nakao N, Miura K, Takahashi H, et al (1986) Hepatocellular carcinoma: combined hepatic arterial and portal venous embolization. Radiology 161:303–307
Nakao N, Kamino K, Miura K, et al (1991) Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization. AJR 156:1177–1179
Nakao N, Uchida H, Kamino K, et al (1994) Determination of the optimum dose level of Lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc Intervent Radiol 17(2):76–80
Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK, Tso WK (1993) Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol 47:315–320
Ohno K, Yamada K, Nakamura T, et al (1994) Usefulness and safety of segmental-subsegmental TAE for hepatocellular carcinoma in cases of liver hypofunction. Nippon Igaku Hoshasen Gakkai Zasshi 54:798–800
Oi H, Kim T, Kishimoto H, Matsushita M, Tateishi H, Okamura J (1994) Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma. Cancer Chemother Pharmacol 33(Suppl): S69–S73
Okazaki M, Higashihara H, Koganemaru F, et al (1991) Intraperitoneal hemorrhage from hepatocellular carcinoma: emergency chemoembolization or embolization. Radiology 180:647–651
Okazaki M, Higashihara H, Ono H, et al (1993) Chemoembolization for hepatocellular carcinoma via the inferior pancreaticoduodenal artery in patients with celiac artery stenosis. Acta Radiol 34:20–25
Okazaki M, Higashihara H, Shijo H, (1997) Chemoembolization. In: Livraghi T, Makuuchi M, L Buscarini (eds) Diagnosis and treatment of hepatocellular carcinoma. Greenwich Medical Media, London, pp:307–326
Park JH, Han JK, Chung JW, Han MC, Kim ST (1993) Postoperative recurrence of hepatocellular carcinoma: results of transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 16:21–24
Pelletier G, Roche A, Ink O, et al (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181–184
Pelletier G, Ducreux M, Gay F, et al (1998) Treatment of unresectable hepatocellular carcinoma with Lipiodol chemoembolization: a multicenetr randomized trial. J Hepatol 29:129–134
Raoul JL, Bourguet P, Bretagne JF, Duvauferrier R (1988) Hepatic artery injection of I-labeled Lipiodol: biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 168:541–545
Roche A (1991) Chemoembolization of liver malignancies. In: Ferrucci JT, Mathieu DG (eds) Advances in Hepatobiliary Radiology. CV Mosby Company, Baltimore, pp 295–305
Roche A (1996) Angiography in hepatocellular carcinoma. In Livraghi T, Makuuchi M, Buscarini L (eds) Diagnosis and treatment of hepatocellular carcinoma. Greenwich Medical Media, London, pp 129–139
Roche A, Doyon D, Harry G, Weingarten A, Edouard A (1978) L’embolisation artérielle hépatique: à propos de 35 cas. Nouvelle Presse Médicale 7:633–637
Roche A, Franco D, Dhumeau D, Bismuth H, Doyon D (1979) Emergency hepatic arterial embolization for secondary hypercalcemia in hepatocellular carcinoma. Radiology 133:315–316
Sato M, Yamada R, Uchida B, Hedgepeth P, Rösch J (1993) Effects of hepatic artery embolization with Lipiodol and gelatine sponge particles on normal swine liver. Cardiovasc Intervent Radiol 16:348–354
Savastano S, Feltrin GP, Miotto D, Chiesura-Corona M, Casarrubea G, Cecchetto A (1994) The preoperative chemoembolization of hepatocarcinoma due to cirrhosis. Radiol Med 88:620–624
Sigurdson E, Ridge J, Daly J (1986) Intra-arterial infusion of doxorubicin with degradable starch microspheres. Arch Surg 121:1277–1281
Soyer P, Roche A, Rougier P, Levesque M, (1992) Nonresectable fibrolamellar hepatocellular carcinoma: outcome of 4 cases treated by intra-arterial chemotherapy. J Belge Radiol 75:463–468
Soyer P, van Beers B, Goffette P, Zeitoun G, Pringot J, Levesque M, (1993) The role of embolization and chemo-embolization in the emergency treatment of hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma. Gastroenterol Clin Biol 17:643–648
Spreafico C, Marchiano A, Regalia E, et al (1994) Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 192:687–690
Stuart K, Stokes K, Jenkins R, Trey C, Clouse M, (1993) Treatment of hepatocellular carcinoma using doxorubicin/ ethiodized oil/gelatin powder chemoembolization. Cancer 72:3202–3209
Takayasu K, Shima Y, Muramatsu Y, et al (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 162:345–351
Tanaka K, Nakamura S, Numata K, et al (1992) Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185:457–460
Taniguchi K, Nakata K, Kato Y, et al (1994) Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Cancer 73:1341–1345
Uchida H, Matsuo N, Nishimine K, Nishimura Y, Sakaguchi H, Ohishi H, (1993) Transcatheter arterial embolization for hepatoma with Lipiodol. Sem Intervent Radiol 10:19–26
Urata K, Matsumata T, Kamakura T, Hasuo K, Sugimachi K (1994) Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis. J Surg Oncol 56:54–58
van Beers B, Roche A, Jamart J, Cauquil P, Pariente D, Derhy S (1989) Iodized oil retention of hepatocellular carcinoma on CT after transcatheter chemotherapy. Acta Radiol 30:415–418
Vetter D, Wenger JJ, Bergier JM, Doffoel M, Bockel R (1991) Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a western comparative study in 60 patients. Hepatology 13:427–433
Wang XW, Jia L, Sun Z, Harris C (1997) Interactive effects of p53 tumor suppressor gene and hepatitis B virus in hepatocellular carcinoma. In: Arroyo V, Bosch J, Bruguera M, Rodes J (eds) Therapy in liver diseases. The pathophysiological basis of therapy. Masson, Barcelona, pp 471–478
Xu HB, Yan XQ (1993) Diagnosis and therapy for primary hepatic carcinoma: transcatheter inferior phrenic arteriography and chemoembolization. J Tongji Med Univ 13:186–189
Yamada R, Sato M, Nomura S, Yamada T, Nakatsuka H (1985) Transcatheter arterial embolization of hepatocellular carcinoma: results of 519 cases in 7 years 9 months. JJpn Soc Cancer Ther 20:1627
Yamakado K, Hirano T, Kato N, et al (1994) Hepatocellular carcinoma: treatment with a combination of transcatheter arterial chemoembolization and transportal ethanol injection. Radiology 193:75–80
Yoshikawa M, Saisho H, Ebara M, et al (1994) A randomized trial of intraarterial infusion of 4’-epidoxorubicin with Lipiodol versus 4’-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Cherrother Pharmacol 33 (Suppl):S149–S152
Yoshimi F, Nagao T, Inoue S, et al (1992) Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial. Hepatology 16:702–706
Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P (1993) Experience with liver resection after hepatic arterial. chemoembolization for hepatocellular carcinoma. Cancer 71:62–65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Roche, A. (1999). Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. In: Bartolozzi, C., Lencioni, R. (eds) Liver Malignancies. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58641-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-58641-5_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63679-0
Online ISBN: 978-3-642-58641-5
eBook Packages: Springer Book Archive